Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial

Background: The addition of ezetimibe to statin therapy has been reported to result in increased efficacy for reduction of LDL-C levels and achievement of lipid targets, compared with monotherapy. Objective: This study was designed to demonstrate the noninferiority of therapy with fixed-dose rosuvas...

Descripción completa

Detalles Bibliográficos
Autores principales: Vattimo, Antonio Carlos Amedeo, Fonseca, Francisco Antonio Helfestein, Morais, Douglas Costa, Generoso, Larissa Fontes, Herrera, Renata, Barbosa, Cristiane Moraes, de Oliveira Izar, Maria Cristina, Cardoso, Rita Antonelli, Zung, Stevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451794/
https://www.ncbi.nlm.nih.gov/pubmed/32904162
http://dx.doi.org/10.1016/j.curtheres.2020.100595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451794/
https://www.ncbi.nlm.nih.gov/pubmed/32904162
http://dx.doi.org/10.1016/j.curtheres.2020.100595

Ejemplares similares